This document outlines the use of saliva as a diagnostic sample for detecting SARS-CoV-2 infection, considering the advantages, limitations and uncertainties associated with the use of saliva as sample material.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 May-4 June 2022 and includes updates on West Nile virus infection, COVID-19, Influenza, people displaced from Ukraine, hepatitis, Ebola, monkeypox, cholera, chikungunya and dengue.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 April 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, hepatitis, Ebola, cholera and poliomyelitis.
In this report, we present an update of the 2020 primary systematic review, to take into account more recent evidence on the efficacy, effectiveness and safety of newer and/or enhanced seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals aged 18 years and over.
This guidance report lays down the scientific basis for the potential introduction of human papillomavirus (HPV) vaccines in order to help EU Member States to make policy choices
This document assesses the potential risk of outbreaks and transmission of communicable diseases during the Hajj taking place between 30 August and 4 September 2017.
Pertussis is an endemic disease in the EU/EEA and worldwide. Every three to five years, larger epidemics are expected even with high vaccination coverage.